Ocugen (OCGN) Cash & Equivalents (2014 - 2026)
Ocugen's Cash & Equivalents came in at $100.1 million for Q2 2026, up 270.6% from $27.01 million a year earlier.
Analysis
Ocugen (OCGN) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Ocugen's Cash & Equivalents was $18.57 million.
- Cash & Equivalents carries a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $39.46 million in FY2023 (-49.1%), $77.56 million in FY2022 (-18.3%) and $94.96 million in FY2021 (+295.0%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q3 2022.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 461.9%), and the weakest in Q2 2024 (a decline of 77.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ocugen | 339.04 Mn | 155.56 Mn | - | 100.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.10 Mn |
| Dec 31, 2025 | 18.57 Mn |
| Jun 30, 2025 | 27.01 Mn |
| Mar 31, 2025 | 37.80 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Mar 31, 2024 | 26.40 Mn |
| Dec 31, 2023 | 39.46 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 70.58 Mn |
| Mar 31, 2023 | 68.26 Mn |
| Dec 31, 2022 | 77.56 Mn |
| Sep 30, 2022 | 101.60 Mn |
| Jun 30, 2022 | 115.01 Mn |
| Mar 31, 2022 | 129.77 Mn |
| Dec 31, 2021 | 94.96 Mn |
| Sep 30, 2021 | 107.35 Mn |
| Jun 30, 2021 | 115.64 Mn |
| Mar 31, 2021 | 44.79 Mn |
| Dec 31, 2020 | 24.04 Mn |
| Sep 30, 2020 | 19.11 Mn |
API Access
Ocugen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OCGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();